1. Home
  2. SVRA vs ATEX Comparison

SVRA vs ATEX Comparison

Compare SVRA & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • ATEX
  • Stock Information
  • Founded
  • SVRA N/A
  • ATEX 1997
  • Country
  • SVRA United States
  • ATEX United States
  • Employees
  • SVRA N/A
  • ATEX N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • ATEX Telecommunications Equipment
  • Sector
  • SVRA Health Care
  • ATEX Telecommunications
  • Exchange
  • SVRA Nasdaq
  • ATEX Nasdaq
  • Market Cap
  • SVRA 458.2M
  • ATEX 555.0M
  • IPO Year
  • SVRA N/A
  • ATEX N/A
  • Fundamental
  • Price
  • SVRA $2.85
  • ATEX $28.32
  • Analyst Decision
  • SVRA Buy
  • ATEX Strong Buy
  • Analyst Count
  • SVRA 7
  • ATEX 2
  • Target Price
  • SVRA $9.86
  • ATEX $68.00
  • AVG Volume (30 Days)
  • SVRA 1.0M
  • ATEX 139.2K
  • Earning Date
  • SVRA 03-06-2025
  • ATEX 02-11-2025
  • Dividend Yield
  • SVRA N/A
  • ATEX N/A
  • EPS Growth
  • SVRA N/A
  • ATEX N/A
  • EPS
  • SVRA N/A
  • ATEX N/A
  • Revenue
  • SVRA N/A
  • ATEX $5,607,000.00
  • Revenue This Year
  • SVRA N/A
  • ATEX $53.57
  • Revenue Next Year
  • SVRA N/A
  • ATEX $0.93
  • P/E Ratio
  • SVRA N/A
  • ATEX N/A
  • Revenue Growth
  • SVRA N/A
  • ATEX 97.01
  • 52 Week Low
  • SVRA $2.59
  • ATEX $27.37
  • 52 Week High
  • SVRA $5.70
  • ATEX $42.41
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 45.63
  • ATEX 38.61
  • Support Level
  • SVRA $2.62
  • ATEX $27.72
  • Resistance Level
  • SVRA $2.88
  • ATEX $29.99
  • Average True Range (ATR)
  • SVRA 0.19
  • ATEX 1.44
  • MACD
  • SVRA 0.02
  • ATEX 0.04
  • Stochastic Oscillator
  • SVRA 40.37
  • ATEX 17.69

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About ATEX Anterix Inc.

Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.

Share on Social Networks: